Subject matter expert VIII support
Ended Awarded Last action
- Contract number
- 75F40123F19264
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $356,062
Award facts
- Contract value 52% obligated
-
- $356,061.96 Current, with exercised options
- $689,585.30 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$122,302 | |
| Funding Only Action | $144,841 | |
| Original award | $333,523 |
About this award
The Food and Drug Administration issued a BPA call under the GSA Multiple Award Schedule to Brillient Corporation on February 14, 2023, for Subject Matter Expert VIII Support with a ceiling value of $689,585.30. Brillient is a minority-owned, Competitive 8(a)-designated corporation.
Performance occurs in Reston, Virginia. The call completed on August 26, 2024. Work is priced on a labor-hours basis.
In FY2024, the call generated $228 thousand in government-invoiced labor across 976 contractor hours (0.5 FTEs), with a derived hourly rate of $233.77. In FY2023, the call invoiced $106 thousand against 4 contractor hours at a derived rate of $30,319.18 per hour. FY2024 pricing is more typical of Brillient's labor-rates portfolio; FY2023's rate reflects minimal utilization. Brillient self-performed all reported hours with no subcontractor engagement.
Quick answers
Who was awarded contract 75F40123F19264?
75F40123F19264 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on February 14, 2023.
How much is contract 75F40123F19264 worth?
The government has obligated $356,062 on 75F40123F19264. Its potential value, with all options, is $689,585.
Is contract 75F40123F19264 an order under another contract?
Yes. 75F40123F19264 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19264 competed?
The extent of competition for 75F40123F19264 was full and open competition. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award